These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7927990)

  • 1. BCG-induced mucosal immune responses.
    Gheorghiu M
    Int J Immunopharmacol; 1994; 16(5-6):435-44. PubMed ID: 7927990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen.
    Lagranderie M; Murray A; Gicquel B; Leclerc C; Gheorghiu M
    Vaccine; 1993 Oct; 11(13):1283-90. PubMed ID: 8296480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route.
    Lagranderie M; Ravisse P; Marchal G; Gheorghiu M; Balasubramanian V; Weigeshaus EH; Smith DW
    Tuber Lung Dis; 1993 Feb; 74(1):38-46. PubMed ID: 8495019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.
    Gheorghiu M; Lagranderie MR; Gicquel BM; Leclerc CD
    Infect Immun; 1994 Oct; 62(10):4287-95. PubMed ID: 7927686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen.
    Lagranderie M; Lo-Man R; Dériaud E; Gicquel B; Gheorghiu M; Leclerc C
    Infect Immun; 1997 Aug; 65(8):3057-64. PubMed ID: 9234754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular oxidative responses and mycobacterial growth inhibition in aerosol and intradermal BCG-immunized guinea-pigs.
    Lagranderie M; Frehel C; de Chastellier C; Gheorghiu M
    Biologicals; 1991 Oct; 19(4):335-45. PubMed ID: 1665701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined intrarectal/intradermal inoculation of recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces enhanced immune responses against the inserted HIV-1 V3 antigen.
    Kawahara M; Matsuo K; Nakasone T; Hiroi T; Kiyono H; Matsumoto S; Yamada T; Yamamoto N; Honda M
    Vaccine; 2002 Dec; 21(3-4):158-66. PubMed ID: 12450689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Mar; 24(10):1593-600. PubMed ID: 16257099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
    Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
    Goonetilleke NP; McShane H; Hannan CM; Anderson RJ; Brookes RH; Hill AV
    J Immunol; 2003 Aug; 171(3):1602-9. PubMed ID: 12874255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
    Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
    Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity.
    Kawahara M; Hashimoto A; Toida I; Honda M
    Clin Immunol; 2002 Dec; 105(3):326-31. PubMed ID: 12498814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
    Kawahara M
    Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity elicited by rBCG vaccines.
    Stover CK; Bansal GP; Langerman S; Hanson MS
    Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.